Table 2—

ORs for predictors for diabetes in the exploratory cohort

InterceptModel 1: simple modelModel 2: model 1 with IFGModel 3: model 1 with IGTModel 4: mode l with IGT, TGsModel 5: model 1 with IGT, TGs, HDL cholesterolModel with IFG onlyModel with IGT only
Age (years)
    35–3911111
    40–440.93 (0.65–1.33)0.91 (0.64–1.30)0.87 (0.60–1.25)0.87 (0.60–1.25)0.87 (0.60–1.25)
    45–491.31 (0.90–1.91)1.28 (0.88–1.86)1.10 (0.75–1.62)1.06 (0.72–1.57)1.11 (0.75–1.64)
    ≥501.83 (1.07–3.12)1.84 (1.08–3.14)1.47 (0.84–2.56)1.43 (0.82–2.50)1.45 (0.82–2.54)
Sex (men)1.55 (1.06–2.29)1.46 (0.99–2.15)1.88 (1.26–2.81)1.68 (1.12–2.52)1.76 (1.17–2.66)
BMI (kg/m2)
    <2311111
    ≥23 but <27.52.00 (1.42–2.83)1.97 (1.35–2.71)1.84 (1.29–2.81)1.74 (1.22–2.49)1.71 (1.19–2.44)
    ≥27.53.44 (1.91–6.17)3.43 (1.88–6.21)3.15 (1.72–5.78)3.02 (1.64–5.54)2.83 (1.53–5.22)
Waist circumference ≥90 cm in men, ≥80 cm in women1.74 (1.17–2.60)1.74 (1.17–2.60)1.78 (1.18–2.70)1.69 (1.11–2.56)1.69 (1.11–2.55)
Hypertension1.90 (1.36–2.64)1.91 (1.37–2.65)1.73 (1.23–2.44)1.67 (1.18–2.36)1.69 (1.19–2.39)
History of diabetes in parent or sibling2.95 (2.22–3.92)2.89 (2.17–3.85)2.75 (2.05–3.69)2.74 (2.04–3.67)2.74 (2.04–3.68)
IFG2.07 (1.39–3.10)2.41 (1.78–3.28)
IGT4.18 (3.04–5.75)4.08 (2.96–5.62)4.10 (2.97–5.65)4.36 (3.41–5.57)
TGs ≥200 mg/dl1.66 (1.19–2.32)1.53 (1.08–2.16)
HDL cholesterol <40 mg/dl in men, <50 mg/dl in women1.39 (1.02–1.91)
AUC0.748 (0.714–0.781)0.756 (0.722–0.789)0.781 (0.748–0.814)0.786 (0.754–0.818)0.790 (0.758–0.823)0.548 (0.528–0.569)0.628 (0.602–0.654)
Goodness of fit (P value)0.80.880.770.990.92<0.01<0.01
  • Data are OR (95% CI) unless otherwise indicated. IFG was defined as fasting plasma glucose ≥100 and <126 mg/dl; IGT was defined as plasma glucose ≥140 and <200 mg/dl 2 h after the ingestion of a standard 75-g glucose load. TGs, triglycerides.